LAG3 and cancer: To test this possibility, we incubated cancer cells (RKO that express endogenous PD-L1) with Jurkat T cells that express LAG-3 (Fig. 2a, b) or TIGIT (Fig. 2c, d), in the presence of GB265, GB266, GB266T, or control monospecific antibodies.